![[OPPORTUNITY] Resilient AI Challenge: Building the Next Generation of Sustainable and Robust AI](https://static.wixstatic.com/media/d57139_6abfe15a4c034118ad7a0f1c460879a0~mv2.png/v1/fill/w_995,h_800,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/d57139_6abfe15a4c034118ad7a0f1c460879a0~mv2.png)
![[OPPORTUNITY] Resilient AI Challenge: Building the Next Generation of Sustainable and Robust AI](https://static.wixstatic.com/media/d57139_6abfe15a4c034118ad7a0f1c460879a0~mv2.png/v1/fill/w_408,h_328,fp_0.50_0.50,q_95,enc_avif,quality_auto/d57139_6abfe15a4c034118ad7a0f1c460879a0~mv2.png)
PhD offer in tumor immunology
- Sep 17, 2021
- 1 min read
Role of B cells and plasma cell subsets in tumor immune surveillance through a comprehensive exploration of tumors associated with paraneoplastic syndromes (PNS)
A PhD position is available within the team “Cancer Immune Surveillance and Therapeutic Targeting” (CISTAR) from the Cancer Research Center of Lyon (CRCL, www.crcl.fr). Interested candidates should submit a motivation letter, CV, master 2 marks and ranking with contact details of 1 or 2 references to Bertrand Dubois (Bertrand.dubois@lyon.unicancer.fr) before October 1st 2021.
Comments